Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 1,528 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 15 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,930 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F16 · kind: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 220,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches. F13 · price: Not applicable. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 1,528 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 14 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F16 · kind: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 220,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches. F13 · price: Not applicable. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Tax withholdingOrdinary Shares | 19,971 | $7.50 | $149,782.50 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 13 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,874 F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F15 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 12,733 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 12 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F14 · kind: On February 1, 2019, the Reporting Person was granted 38,200 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021, and January 31, 2022. The second vesting event occurred on January 29, 2021. F13 · price: Not applicable. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 26,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 11 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F12 · kind: On February 1, 2018, the Reporting Person was granted 78,000 Restricted Stock Units ("RSUs") under the Plan. These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020, and January 31, 2021. The third and final vesting event occurred on January 29, 2021. F13 · price: Not applicable. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 1,806 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000646 · primarydocument.xml · derivative · entry 10 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,636 Underlying: Ordinary Shares · 1,806 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F6 · derivative.exercise_date: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 260,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 1,806 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000646 · primarydocument.xml · derivative · entry 9 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,636 Underlying: Ordinary Shares · 1,806 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F6 · derivative.exercise_date: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 260,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 12,733 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000646 · primarydocument.xml · derivative · entry 8 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,733 Underlying: Ordinary Shares · 12,733 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F4 · derivative.exercise_date: On February 1, 2019, the Reporting Person was granted 38,200 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021, and January 31, 2022. The second vesting event occurred on January 29, 2021. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 26,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000646 · primarydocument.xml · derivative · entry 7 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 26,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 1, 2018, the Reporting Person was granted 78,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020, and January 31, 2021. The third and final vesting event occurred on January 29, 2021. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Tax withholdingOrdinary Shares | 1,360 | $7.50 | $10,200.00 |
DisclosureSEC source: 0001562180-21-000646 · primarydocument.xml · nonDerivative · entry 6 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,033 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F7 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionOrdinary Shares | 1,806 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-000646 · primarydocument.xml · nonDerivative · entry 5 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6 · kind: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 260,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches. F3 · price: Not applicable. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionOrdinary Shares | 1,806 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-000646 · primarydocument.xml · nonDerivative · entry 4 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6 · kind: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 260,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches. F3 · price: Not applicable. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Tax withholdingOrdinary Shares | 15,351 | $7.50 | $115,132.50 |
DisclosureSEC source: 0001562180-21-000646 · primarydocument.xml · nonDerivative · entry 3 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,781 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionOrdinary Shares | 12,733 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-000646 · primarydocument.xml · nonDerivative · entry 2 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: On February 1, 2019, the Reporting Person was granted 38,200 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021, and January 31, 2022. The second vesting event occurred on January 29, 2021. F3 · price: Not applicable. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionOrdinary Shares | 26,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-000646 · primarydocument.xml · nonDerivative · entry 1 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: On February 1, 2018, the Reporting Person was granted 78,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020, and January 31, 2021. The third and final vesting event occurred on January 29, 2021. F3 · price: Not applicable. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:01 UTC |
THERO JOHN FDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 6,736 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000645 · primarydocument.xml · derivative · entry 10 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,152 Underlying: Ordinary Shares · 6,736 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F6 · derivative.exercise_date: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 970,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:01 UTC |
THERO JOHN FDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 6,736 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000645 · primarydocument.xml · derivative · entry 9 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,152 Underlying: Ordinary Shares · 6,736 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F6 · derivative.exercise_date: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 970,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:01 UTC |
THERO JOHN FDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 72,033 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000645 · primarydocument.xml · derivative · entry 8 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,033 Underlying: Ordinary Shares · 72,033 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F4 · derivative.exercise_date: On February 1, 2019, the Reporting Person was granted 216,100 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021, and January 31, 2022. The second vesting event occurred on January 29, 2021. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:01 UTC |
THERO JOHN FDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 123,666 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000645 · primarydocument.xml · derivative · entry 7 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 123,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 1, 2018, the Reporting Person was granted 371,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020, and January 31, 2021. The third and final vesting event occurred on January 29, 2021. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:01 UTC |
THERO JOHN FDirector · President and CEO
|
Tax withholdingOrdinary Shares | 5,302 | $7.50 | $39,765.00 |
DisclosureSEC source: 0001562180-21-000645 · primarydocument.xml · nonDerivative · entry 6 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,881,749 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F7 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:01 UTC |
THERO JOHN FDirector · President and CEO
|
Exercise / conversionOrdinary Shares | 6,736 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-000645 · primarydocument.xml · nonDerivative · entry 5 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,887,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6 · kind: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 970,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches. F3 · price: Not applicable. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:01 UTC |
THERO JOHN FDirector · President and CEO
|
Exercise / conversionOrdinary Shares | 6,736 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-000645 · primarydocument.xml · nonDerivative · entry 4 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,880,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6 · kind: As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 970,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches. F3 · price: Not applicable. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:01 UTC |
THERO JOHN FDirector · President and CEO
|
Tax withholdingOrdinary Shares | 77,460 | $7.50 | $580,950.00 |
DisclosureSEC source: 0001562180-21-000645 · primarydocument.xml · nonDerivative · entry 3 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,873,579 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:01 UTC |
THERO JOHN FDirector · President and CEO
|
Exercise / conversionOrdinary Shares | 72,033 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-000645 · primarydocument.xml · nonDerivative · entry 2 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,951,039 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: On February 1, 2019, the Reporting Person was granted 216,100 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021, and January 31, 2022. The second vesting event occurred on January 29, 2021. F3 · price: Not applicable. Read SEC document |
| January 29, 2021 Filed Jan 30, 2021 01:01 UTC |
THERO JOHN FDirector · President and CEO
|
Exercise / conversionOrdinary Shares | 123,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-000645 · primarydocument.xml · nonDerivative · entry 1 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,879,006 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: On February 1, 2018, the Reporting Person was granted 371,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020, and January 31, 2021. The third and final vesting event occurred on January 29, 2021. F3 · price: Not applicable. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 85,313 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 24 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,687 Underlying: Ordinary Shares · 85,313 shares Expires 2028-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: On February 1, 2018 the Reporting Person was granted an option to purchase 117,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2018. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 47,605 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 23 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,082 Underlying: Ordinary Shares · 47,605 shares Expires 2027-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2017. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 23,436 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 22 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 23,436 shares Expires 2026-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on February 29, 2016. This option was fully vested as of the date hereof. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 29,427 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 21 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,573 Underlying: Ordinary Shares · 29,427 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 240,000 Ordinary Shares under the Plan. The vesting of the shares was subject to a certain performance milestone that was previously achieved. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 52,938 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 20 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 52,938 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares was subject to a certain performance milestone that was previously achieved. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,797 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 19 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,703 Underlying: Ordinary Shares · 5,797 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares was subject to a certain performance milestone that was previously achieved. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,332 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 18 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,332 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,389 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · derivative · entry 17 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 25,389 shares Expires 2025-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On February 2, 2015, the Reporting Person was granted an option to purchase 93,750 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on February 28, 2015. This option was fully vested as of the date hereof. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
SaleOrdinary Shares | 143,392 | $8.01 | $1,149,258.20 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 10 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388,112 F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
SaleOrdinary Shares | 278,237 | $8.01 | $2,228,873.14 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 9 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,504 F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 85,313 | $3.80 | $324,189.40 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 8 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 809,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F9 · kind: On February 1, 2018 the Reporting Person was granted an option to purchase 117,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2018. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 47,605 | $2.95 | $140,434.75 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 7 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 724,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F8 · kind: On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2017. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 23,436 | $1.40 | $32,810.40 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 6 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 676,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F7 · kind: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on February 29, 2016. This option was fully vested as of the date hereof. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 29,427 | $2.50 | $73,567.50 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 5 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 653,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6 · kind: On July 6, 2015, the Reporting Person was granted an option to purchase 240,000 Ordinary Shares under the Plan. The vesting of the shares was subject to a certain performance milestone that was previously achieved. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 52,938 | $2.50 | $132,345.00 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 4 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 623,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · kind: On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares was subject to a certain performance milestone that was previously achieved. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 5,797 | $2.50 | $14,492.50 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 571,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · kind: On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares was subject to a certain performance milestone that was previously achieved. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 8,332 | $2.50 | $20,830.00 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof. Read SEC document |
| January 27, 2021 Filed Jan 30, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 25,389 | $1.02 | $25,896.78 |
DisclosureSEC source: 0001562180-21-000647 · primarydocument.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · kind: On February 2, 2015, the Reporting Person was granted an option to purchase 93,750 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on February 28, 2015. This option was fully vested as of the date hereof. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 01:05 UTC |
Berg AaronCHIEF COMMERCIAL OFFICER
|
GrantRestricted Stock Units · Derivative | 143,300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000129 · primarydocument.xml · derivative · entry 7 Berg Aaron · CIK 0001770259 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,300 Underlying: Ordinary Shares · 143,300 shares Expires not disclosed F6 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F8 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted 143,300 RSUs under the 2020 Plan. These RSUs vest in three equal installments on each of December 31, 2021, December 31, 2022 and December 31, 2023. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 01:05 UTC |
Berg AaronCHIEF COMMERCIAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 193,500 | $0.00 Strike: $5.03 | $0.00 |
DisclosureSEC source: 0001562180-21-000129 · primarydocument.xml · derivative · entry 6 Berg Aaron · CIK 0001770259 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,500 Underlying: Ordinary Shares · 193,500 shares Expires 2031-01-04 F7 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted an option to purchase 193,500 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "2020 Plan" and, together with the 2011 Plan, the "Plans"). The shares subject to this option shall vest and become exercisable over four years, with 25% to vest on the first anniversary of the grant date and the balance to vest ratably over the subsequent 12 calendar quarters on the last day of each March, June, September and December. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 01:04 UTC |
Kalb Michael WayneSVP and CFO
|
GrantRestricted Stock Units · Derivative | 143,300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000128 · primarydocument.xml · derivative · entry 7 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,300 Underlying: Ordinary Shares · 143,300 shares Expires not disclosed F6 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F8 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted 143,300 RSUs under the 2020 Plan. These RSUs vest in three equal installments on each of December 31, 2021, December 31, 2022 and December 31, 2023. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 01:04 UTC |
Kalb Michael WayneSVP and CFO
|
GrantStock Option (Right to Buy) · Derivative | 193,500 | $0.00 Strike: $5.03 | $0.00 |
DisclosureSEC source: 0001562180-21-000128 · primarydocument.xml · derivative · entry 6 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,500 Underlying: Ordinary Shares · 193,500 shares Expires 2031-01-04 F7 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted an option to purchase 193,500 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "2020 Plan" and, together with the 2011 Plan, the "Plans"). The shares subject to this option shall vest and become exercisable over four years, with 25% to vest on the first anniversary of the grant date and the balance to vest ratably over the subsequent 12 calendar quarters on the last day of each March, June, September and December. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 143,300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000127 · primarydocument.xml · derivative · entry 7 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,300 Underlying: Ordinary Shares · 143,300 shares Expires not disclosed F6 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F8 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted 143,300 RSUs under the 2020 Plan. These RSUs vest in three equal installments on each of December 31, 2021, December 31, 2022 and December 31, 2023. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 01:03 UTC |
Ketchum Steven BChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 193,500 | $0.00 Strike: $5.03 | $0.00 |
DisclosureSEC source: 0001562180-21-000127 · primarydocument.xml · derivative · entry 6 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,500 Underlying: Ordinary Shares · 193,500 shares Expires 2031-01-04 F7 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted an option to purchase 193,500 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "2020 Plan" and, together with the 2011 Plan, the "Plans"). The shares subject to this option shall vest and become exercisable over four years, with 25% to vest on the first anniversary of the grant date and the balance to vest ratably over the subsequent 12 calendar quarters on the last day of each March, June, September and December. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 01:03 UTC |
Kennedy Joseph TGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 143,300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000126 · primarydocument.xml · derivative · entry 7 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,300 Underlying: Ordinary Shares · 143,300 shares Expires not disclosed F6 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F8 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted 143,300 RSUs under the 2020 Plan. These RSUs vest in three equal installments on each of December 31, 2021, December 31, 2022 and December 31, 2023. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.